Warning: "continue" targeting switch is equivalent to "break". Did you mean to use "continue 2"? in /hermes/bosnacweb06/bosnacweb06ae/b2867/dot.galectintx/wp-content/themes/wp_bullet/inc/ReduxCore/extensions/customizer/extension_customizer.php on line 358
Warning: "continue" targeting switch is equivalent to "break". Did you mean to use "continue 2"? in /hermes/bosnacweb06/bosnacweb06ae/b2867/dot.galectintx/wp-content/themes/wp_bullet/inc/ReduxCore/extensions/customizer/extension_customizer.php on line 380
Warning: "continue" targeting switch is equivalent to "break". Did you mean to use "continue 2"? in /hermes/bosnacweb06/bosnacweb06ae/b2867/dot.galectintx/wp-content/themes/wp_bullet/inc/ReduxCore/extensions/customizer/extension_customizer.php on line 384
Warning: "continue" targeting switch is equivalent to "break". Did you mean to use "continue 2"? in /hermes/bosnacweb06/bosnacweb06ae/b2867/dot.galectintx/wp-content/themes/wp_bullet/inc/ReduxCore/extensions/customizer/extension_customizer.php on line 411
Warning: "continue" targeting switch is equivalent to "break". Did you mean to use "continue 2"? in /hermes/bosnacweb06/bosnacweb06ae/b2867/dot.galectintx/wp-content/themes/wp_bullet/inc/ReduxCore/extensions/customizer/extension_customizer.php on line 423
Warning: "continue" targeting switch is equivalent to "break". Did you mean to use "continue 2"? in /hermes/bosnacweb06/bosnacweb06ae/b2867/dot.galectintx/wp-content/themes/wp_bullet/inc/ReduxCore/extensions/customizer/extension_customizer.php on line 442
Warning: Cannot modify header information - headers already sent by (output started at /hermes/bosnacweb06/bosnacweb06ae/b2867/dot.galectintx/wp-content/themes/wp_bullet/inc/ReduxCore/extensions/customizer/extension_customizer.php:358) in /hermes/bosnacweb06/bosnacweb06ae/b2867/dot.galectintx/wp-includes/feed-rss2-comments.php on line 8
Comments for NASH & Liver Fibrosis | Galectin Therapeutics
http://perspectives.galectintherapeutics.com
The Official Blog of Galectin Therapeutics
Wed, 19 Apr 2017 16:04:41 +0000
hourly
1 https://wordpress.org/?v=5.1.18
Comment on Successful Phase 1 Clinical Trial Supports Phase 2 Clinical Development Program by Galectin Expects Data from Phase 2 NASH Cirrhosis Trial by December
http://perspectives.galectintherapeutics.com/successful-phase-1-clinical-trial-supports-phase-2-clinical-development-program/#comment-27
Wed, 19 Apr 2017 16:04:41 +0000http://perspectives.galectintherapeutics.com/?p=13594#comment-27[…] powerful drug with therapeutic effects in NASH patients with advanced fibrosis and cirrhosis. These results supported the initiation of Phase 2 clinical trials to further determine the drug’s safety […]
]]>
Comment on Pulmonary Arterial Hypertension is Associated with Elevated Levels of Galectin-3 and a Potential Therapeutic Target for GR-MD-02 by Galectin-3 Inhibitors Show Positive Preclinical Results for PAH Vascular Remodeling | BioNewsFeeds
http://perspectives.galectintherapeutics.com/pulmonary-arterial-hypertension-is-associated-with-elevated-levels-of-galectin-3-and-a-potential-therapeutic-target-for-gr-md-02/#comment-25
Wed, 08 Jun 2016 18:39:07 +0000http://perspectives.galectintherapeutics.com/?p=13735#comment-25[…] The study’s results showed that animal models of PAH have significantly “increased right ventricular systolic pressure, right ventricular hypertrophy and pulmonary arterial smooth muscle proliferation and fibrosis,” in addition to “increased right ventricular wall thickness and lower pulmonary blood flow.” […]
]]>